HomePCVX • NASDAQ
add
Vaxcyte Inc
Previous close
$75.45
Day range
$73.98 - $75.79
Year range
$44.20 - $82.04
Market cap
8.11B USD
Avg Volume
671.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 114.47M | 60.79% |
Net income | -95.02M | -57.16% |
Net profit margin | — | — |
Earnings per share | -0.85 | -21.56% |
EBITDA | -113.47M | -61.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.49B | 80.83% |
Total assets | 2.09B | 107.44% |
Total liabilities | 107.32M | 69.30% |
Total equity | 1.98B | — |
Shares outstanding | 108.80M | — |
Price to book | 4.14 | — |
Return on assets | -16.36% | — |
Return on capital | -17.44% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -95.02M | -57.16% |
Cash from operations | -159.12M | -233.66% |
Cash from investing | -451.07M | -0.66% |
Cash from financing | 818.20M | 1,868.62% |
Net change in cash | 214.06M | 147.13% |
Free cash flow | -136.05M | -307.50% |
About
Founded
2013
Headquarters
Website
Employees
254